CHOLIX TOXIN DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

• 收藏
• 分享

专利权人:

发明人:

MRSNY RANDALL J,MAHMOOD TAHIR

申请号：

IN201617041645

公开号：

IN201617041645A

申请日:

2016.12.06

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

The present disclosure relates to pharmaceutical compositions comprising a non naturally occurring fusion molecule and one or more pharmaceutically acceptable carriers formulated for oral delivery to a subject and designed to provide for improved effective therapies for treatment of e.g. inflammatory diseases autoimmune diseases cancer metabolic disorders and growth deficiency disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/